Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2

AIDS Research and Human Retroviruses

Volumn 15, Issue 8, 1999, Pages 713-719

  Raez, Luis ^a   Cabral, Lisa ^a   Cai, Jian Ping ^a   Landy, Howard ^a   Sfakianakis, George ^a   Byrne Jr , Gerald E ^a   Hurley, Judith ^a   Scerpella, Ernesto ^a   Jayaweera, Dushyantha ^a   Harrington Jr , William J ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; INTERLEUKIN 2; ZIDOVUDINE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; BRAIN LYMPHOMA; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; TREATMENT PLANNING; VIRUS DETECTION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; APOPTOSIS; BRAIN NEOPLASMS; DRUG THERAPY, COMBINATION; FEMALE; GANCICLOVIR; HUMANS; INTERLEUKIN-2; LYMPHOMA, AIDS-RELATED; MALE; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; ZIDOVUDINE;

EID: 0033586984     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310809     Document Type: Article

References (28)

1. Ziegler JL, Becksted JA, Volberding PA, et al: Non-hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984;311:565-570.
2. Levine AM, Meyer PR, Begandy MM, et al: Development of B cell lymphoma in homosexual men: Clinical and immunologic findings. Ann Intern Med 1984;100:7-13.
3. Knowles DM, Chamulak GA, Subar M, et al.: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988;108:744-753.
4. Kaplan LD, Abrams DI, Feigal E, et al.: AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989;261:719-724.
5. Baumgartner JE, Rachlin JR, Beckstead JH, et al.: Primary central nervous system lymphomas: Natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990;73(2):206-211.
6. Carbonne A, Dolcetti R, Gloghini A, et al.: Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: A comparative study. Hum Pathol 1996;27(2):133-146.
7. MacMahon EM, Glass JD, Hayward SD, et al.: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991;338(8773):969-973.
8. Cingolani A, De Luca A, Larocca LM, et al.: Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst 1998;90(5):364-369.
9. Ruiz, A, Ganz WI, Donovan Post J, et al: Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. Am J Neurol Res 1994;15:1885-1894.
10. Harrington WJ Jr, Cabral L, Cai J-P, Chan-A-Sue S, and Wood C: Azothymidine and interferon are active in AIDS-associated small non-cleaved cell lymphoma but not large cell lymphoma. Lancet 1996;348:833. [Letter]
11. Baselga J, Krown SE, Telzak EE, Filippa DA, and Straus DJ: Acquired immune deficiency syndrome-related pulmonary non-Hodgkin's lymphoma regressing after zidovudine therapy. Cancer 1993;71(7):2332-2334.
12. Rea D, Delecluse H-J, Hamilton-Dutoit SJ, et al.: Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. Ann Oncol 1994;5(Suppl.1):S113-S116.
13. Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al.: Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J Pathol 1991;165(4):289-299.
14. Farnk D, Cesarman E, Liu YF, Michler RE, and Knowles DM: Post-transplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 1995;85(5):1396-1403.
15. Kurakata S, Ramos OF, Klein G, and Klein E: Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms. Cell Immunol 1989;123:134-147.
16. Clements GB, Klein G, and Povey S: Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int J Cancer 1975;16:125-133.
17. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, and Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545-1556.
18. Chamberlain MC: Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma. Cancer 1994;73(6):1728-1730.
19. Camilleri-Broet S, Davi F, Feuillard J, et al.: High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood 1995;86(2):432-435.
20. Schmitt-Graff A, Hummel M, Anagnostopoulos I, Stoltenburg G, and Stein H: Primary brain lymphoma in acquired immunodeficiency syndrome. Immunophenotype and molecular pathologic characterization in stereotactic biopsy, autopsy, and cerebrospinal fluid cytology. Pathologe 1995;16(1):75-80.
21. Hill ME, MacLennan KA, Cunningham DC, Vaughan Hudson B, Burke M, Clarke P, et al.: Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation Study. Blood 1996;88:1046-1051.
22. Gill PS, Harrington WJ Jr, Kaplan MH, et al.: Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995;332:1744-1748.
23. Tosi P, Gherlinzoni F, Mazza P, et al.: 3′-Azido 3′-deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomas. Blood 1997;89(2):419-425.
24. Lin JC, Zhang ZX, Chou TC, Sim I, and Pagano JS: Synergistic inhibition of Epstein-Barr virus: Transformation of B lymphcytes by alpha and gamma interferon and by 3′-azido-3′-deoxythymidine. J Infect Dis 1989;159:248-254.
25. Ram Z, Culver KW, Oshiro EM, et al.: Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Med 1997;3(12):1354-1361.
26. Lee RK, Deyev V, Spruill G, et al.: AZT induces fas and apoptosis in Burkitt's lymphoma. Blood 1997;90(10):341a. [Supplement 1]
27. Bernstein ZP, Porter MM, Gould M, et al.: Prolonged administration of low-dose interteukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood 1995; 86(9):3287-3294.
28. Baiocchi RA, Khatri VP, Lindemann MJ, et al.: Phenotypic and functional analysis of fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome. Blood 1997;90(5):1737-1746.